Brandon Menke, MD
Ophthalmology · Omaha, NENPI 1912312406
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,347 of the $5,573 with a category attached, or 60.1%. 19 manufacturers reported payments, led by Johnson & Johnson Surgical Vision, Inc. at 41.5% of the total. Reporting peaked in 2019 at $2,672 and has fallen 77.2% since, to $610 in 2025. Among ophthalmology clinicians in NE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 130 payments — averaging $42.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Surgical Vision, Inc.$2K
- Alcon$826
- AbbVie$726
- Rxsight Inc$441
- Bausch & Lomb Americas Inc.$205
- The Cameron-ehlen Group, Inc.$179
- plus $881 from 13 others
What the payments were for
- Consulting fees$2,13238%
- Speaking & faculty fees$581%
- Food & beverage$3,34760%
- Education$180%
- Entertainment$180%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | 5 | $2,314 |
| Alcon | 21 | $826 |
| AbbVie(2 entities) | 40 | $726 |
| Rxsight Inc | 14 | $441 |
| Bausch & Lomb Americas Inc. | 10 | $205 |
| The Cameron-ehlen Group, Inc. | 7 | $179 |
| Biotissue Holdings Inc. | 3 | $170 |
| Glaukos Corporation | 4 | $119 |
| NEW World Medical,inc. | 1 | $112 |
| Sight Sciences, Inc. | 6 | $99 |
| Optos, Inc. | 3 | $84 |
| Astellas Pharma US Inc | 3 | $73 |
| Harrow Eye, LLC | 2 | $47 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $44 |
| Genentech USA, Inc. | 2 | $40 |
| Apellis Pharmaceuticals, Inc. | 2 | $37 |
| Eyepoint US, Inc. | 2 | $27 |
| Carl Zeiss Meditec USA, Inc. | 1 | $18 |
| Aerie Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,573 in reported general payments places this provider in the 90th percentile of 105 ophthalmology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 20 | $1,973 |
| Prednisolone Acetate | 33 | $1,647 |
| Timolol Maleate | 51 | $1,108 |
| Latanoprost | 79 | $1,089 |
| MoxifloxacinMoxifloxacin Hcl | 39 | $1,049 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 52 | $533 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 28 | $197 |
| Acyclovir | 16 | $119 |
| Brimonidine Tartrate | 12 | $114 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Omaha
- Brandon BaartmanOmaha$226K
- Ronald KruegerOmaha$224K
- Lorraine ProvencherOmaha$220K
- Lance KuglerOmaha$41K
- Rao ChunduryOmaha$14K
- Shane HavensOmaha$6K
- Sao LiuOmaha$5K
- Michael HalstedOmaha$4K
- Thomas HejkalOmaha$4K
- Sao LiuOmaha$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.